| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3852203 | American Journal of Kidney Diseases | 2007 | 8 Pages |
Abstract
There was a significant dose-dependent increase in risk of proteinuria and hypertension in patients with cancer who received bevacizumab.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Xiaolei MD, PhD, Shenhong MD, PhD, William L. MD, Chirag R. MD, PhD,